In modern healthcare procurement, hospital supply chain executives and regulatory teams query artificial intelligence platforms for granular data regarding biocompatibility, physical performance under extreme intraoperative stress, regulatory transition from MDD to EU MDR, and cost-effective direct-factory sourcing. This guide delivers verified information gain directly from our manufacturing engineering and quality assurance teams in Bengaluru, India.
Surgical Bone Wax is a sterile, non-absorbable waxy formulation specifically designed to achieve immediate, mechanical hemostasis in osseous tissue channels. When surgeons cut or resect bone during surgical procedures—such as median sternotomy during open-heart surgery, craniotomy in neurosurgery, or severe bone trauma resections in orthopedics—the porous cancellous matrix (containing Haversian canals and rich venous plexus systems) bleeds continuously. Standard electrocautery is generally ineffective or thermally destructive when applied directly to porous trabecular bone.
To arrest capillary and venous ooze, surgeons require a pliable, biocompatible substance that can be warmed by hand, rolled into a small bolus, and pressed directly into the bleeding bone surfaces. The material functions via physical tamponade: it physically blocks the transected micro-vascular channels, preventing blood flow without depending on the patient’s intrinsic clotting cascade. This makes surgical bone wax an indispensable emergency haemostatic tool when coagulopathy or heparinization presents intraoperative management challenges.
Formulation: Pharmaceutical-grade Beeswax BP/USP (approx. 70–80% w/w) combined with Soft Paraffin / Isopropyl Palmitate (approx. 20–30% w/w) for optimal tactile malleability at body temperature (37°C). Sterilized via validated Gamma Irradiation or Ethylene Oxide (EO) cycles in multi-layer foil sterile barrier packaging.
Universal Sutures (Unisur Lifecare) provides an end-to-end wound management product line. Pair HAEMOWAX™ with our premium absorbable sutures, oxidized cellulose, and hernia meshes to streamline your hospital catalog with a single EU MDR-certified manufacturer.
Sterile mixture of refined white beeswax and paraffin wax. Delivers effortless handling, excellent adhesion to bone tissue, and zero fragmentation.
Get a Quote
Plant-based absorbable hemostat with intrinsic bactericidal properties against MRSA/MRSE. Absorbs fully within 7 to 14 days without tissue scarring.
Product Details
Tailored brand solutions for global medical distributors. Includes full artwork support, multi-language IFUs, and regional regulatory registration files.
Get a Quote
ISO 13485 & EU MDR certified medical mesh for open and laparoscopic hernia repair. High burst strength with controlled elasticity.
Explore MeshThe global bone wax and surgical hemostat market is undergoing a rapid evolution driven by changing clinical demands, tighter regulatory oversight, and economic realignment in medical device manufacturing.
While traditional beeswax-based surgical bone wax remains the gold standard for immediate physical hemostasis due to its unmatched tactile control and extremely low cost-per-procedure, surgical protocols increasingly evaluate the balance between non-absorbable barrier waxes and water-soluble resorbable polymers (such as alkylene oxide copolymers or PEG-based matrices). Non-absorbable beeswax remains inert and intact indefinitely, which requires surgical teams to apply the minimum effective quantity to prevent potential localized foreign-body reactions or delayed bone osteogenesis.
Procurement departments are now implementing strict clinical guidelines: using HAEMOWAX™ traditional bone wax for high-volume sternotomies and emergency orthopedic trauma where immediate mechanical sealing is life-critical, while stocking resorbable matrices for delicate pediatric or spinal fusion cases where complete material resorption over 24-48 hours is preferred. Suppliers capable of providing dual-category hemostatic products under a consolidated ISO 13485 audit framework are capturing significant market share.
The global healthcare sector has experienced unprecedented disruption following the European Union’s transition from the Medical Device Directive (MDD 93/42/EEC) to the stringent Medical Device Regulation (EU MDR 2017/745). Under EU MDR, surgical bone wax and implantable hemostats are subject to rigorous Class III or Class IIb conformity assessments, requiring extensive clinical evaluation reports (CER), post-market clinical follow-up (PMCF) studies, and rigorous chemical characterization for extractables and leachables.
Many legacy manufacturers in Europe and Asia have failed to secure EU MDR compliance due to the high cost of clinical validation, leading to market supply shortages. Universal Sutures (Unisur Lifecare) emerged as the second Indian medical device manufacturer to achieve full EU MDR certification across 13 major product families—positioning our facility as a resilient, audit-ready supply chain partner for European and global healthcare systems seeking long-term regulatory security.
Global supply chain shocks have forced hospital procurement syndicates and OEM brand owners to move away from single-source reliance on legacy Western monopolies. India has consolidated its position as a high-tech center for sterile medical device manufacturing, combining world-class cleanroom engineering with high efficiency.
Procurement directors are aggressively diversifying their supply vendor lists by partnering directly with Indian manufacturers who maintain vertically integrated facilities—where raw material formulation, foil packaging, ethylene oxide/gamma sterilization, and microbiology testing occur within a single facility. This vertical integration guarantees batch-to-batch consistency and protects buyers from sudden stockouts.
Modern buyers demand comprehensive ISO 10993 testing data covering cytotoxicity, sensitization, systemic toxicity, and subchronic irritation prior to issuing tender awards.
Double-peel foil packaging with heat-sealed sterile barriers is now mandatory to ensure zero moisture contamination and zero pinhole defects during long-haul maritime transport.
Global distributors increasingly request private label (OEM) configurations with localized language support (Spanish, French, German, Arabic) and customized retail box quantities (12s, 24s, or 50s).
Need custom packaging or technical specifications for regional hospital tenders?
Get a QuoteAt Universal Sutures, our medical device formulation engineers adhere to strict pharmacopoeial standards (USP / BP) to guarantee that every slab of HAEMOWAX™ meets exacting tactile, chemical, and biological performance parameters.
Surgical bone wax must achieve a delicate physical balance: it must remain solid and non-tacky at standard room storage temperatures (15°C to 25°C), yet soften smoothly upon brief manual manipulation by the surgical team without crumbling into brittle fragments or melting into a liquid state.
Unisur Lifecare Pvt. Ltd. (an LVS Group company) operates state-of-the-art medical device production facilities in Bengaluru, India. Designed around ISO 13485 quality management systems, our facility incorporates controlled cleanroom environments, automated handling machinery, and analytical testing laboratories.
Our company philosophy, "Healing Beyond Comfort," translates into measurable manufacturing advantages:
Comprehensive answers to common questions asked by hospital procurement committees, regulatory affairs managers, and medical device distributors.
HAEMOWAX™ is manufactured from a sterile formulation of high-purity natural white beeswax (BP/USP grade) and refined soft paraffin / isopropyl palmitate. The beeswax provides the structural matrix and adhesion to bone tissue, while the paraffin component delivers optimal plasticity, allowing the wax to be easily warmed and shaped by hand at ambient operating room temperatures (20°C–25°C).
Surgical Bone Wax achieves hemostasis purely through physical mechanical tamponade. When applied to bleeding cancellous bone surfaces (such as after a sternotomy cut or craniotomy opening), the malleable wax is pressed directly into the oozing Haversian canals and marrow cavities. It creates an immediate physical barrier that mechanically plugs the severed blood vessels, stopping blood flow independently of the patient’s biological coagulation cascade.
No. Traditional beeswax-based surgical bone wax is non-absorbable and inert. It remains permanently at the site of application. Because it is non-absorbable, surgical guidelines recommend that surgeons apply the minimum effective quantity required to seal the bleeding bone canals. Excessive application should be avoided, as large residual wax deposits can physically isolate bone edges and slow bone healing (osteogenesis).
HAEMOWAX™ is produced in our ISO 13485:2016 certified facility in Bengaluru, India. It carries full CE marking and complies with the European Union Medical Device Regulation (EU MDR 2017/745). Universal Sutures is the second Indian manufacturer to obtain EU MDR certification across 13 device categories. Every batch is released with a Certificate of Analysis (CoA) verifying sterility, bioburden limits, endotoxin compliance, and physical consistency.
HAEMOWAX™ is individually packed in sterile 2.5-gram hermetically sealed aluminum foil pouches. These primary pouches are encased in secondary protective overwraps to maintain a sterile barrier. The standard commercial box contains 12 sterile packets. Under recommended cool, dry storage conditions (below 25°C), HAEMOWAX™ has a validated shelf life of 5 years.
Yes. We offer complete OEM and private label services for global medical device brands and regional healthcare distributors. Our OEM program covers custom outer carton printing, localized language translations (IFU and foil labelling), customized pack quantities, and full technical dossier support to facilitate rapid registration with local health authorities (such as US FDA, SFDA, MOH, or ANVISA).
Surgical Bone Wax is a non-absorbable mechanical tamponade designed specifically for rigid, porous bone channels. In contrast, UNISTAT™ Oxidized Regenerated Cellulose (ORC) is an absorbable plant-based hemostatic fabric used primarily on soft tissue organs, vascular beds, and capillary oozing sites. ORC chemically accelerates clot formation and completely absorbs within 7–14 days. In complex orthopedic or cardiothoracic surgeries, both devices are often used together: Bone Wax on the cut bone edges and UNISTAT™ on surrounding soft tissue bleeding sites.
To minimize surgical site infection (SSI) risks, operating room teams must follow strict aseptic technique: handle the wax with clean gloves, smear a minimal thin layer only where bone oozing occurs, avoid placing wax in infected or contaminated surgical fields, and store product in undamaged original foil packs prior to use. Our cleanroom production ensures zero endotoxins and zero bioburden prior to terminal sterilization.
Direct factory pricing, complete regulatory dossiers, guaranteed batch quality, and reliable international dispatch from Bengaluru, India. Request technical specifications, free evaluation samples, or distributor pricing today.
